BAX Stock May Rise Following the Launch of FDA-Approved Hemopatch Pad

• click to rate

  Posted by Two Blokes May 21 - Filed in Stock - 2 views
  
  Baxter launches Hemopatch Sealing Hemostat, an FDA-approved collagen pad designed for effective hemostasis and sealing in both open and minimally invasive surgeries.